Abkyu is a Boston-based company utilizing advanced immunization strategies and cutting edge discovery approaches to discover VHHs to the industry's most challenging drug targets. Our proprietary discovery technologies allow us to generate robust immune responses on industry leading timelines, and unlock natural immune diversity to identify rare, and therapeutically relevant VHH candidates. Check out our website to learn more! www.abkyu.com